Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $115.0600 (2.54%) ($110.5000 - $117.3400) on Fri. Jul. 10, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.37% (three month average) | RSI | 46 | Latest Price | $115.0600(2.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.6% a day on average for past five trading days. | Weekly Trend | LGND declines -0.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(52%) XBI(50%) IWC(47%) IWM(47%) | Factors Impacting LGND price | LGND will decline at least -1.685% in a week (0% probabilities). VIXM(-22%) UUP(-16%) VXX(-15%) IYT(-4%) UNG(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.685% (StdDev 3.37%) | Hourly BBV | 0 () | Intraday Trend | 4.1% | | | |
|
5 Day Moving Average | $112.57(2.21%) | 10 Day Moving Average | $112.42(2.35%) | 20 Day Moving Average | $112.41(2.36%) | To recent high | -6.9% | To recent low | 30.2% | Market Cap | $1.849b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |